REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 78 filers reported holding REPROS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $454,000 | +107.3% | 687,032 | +0.1% | 0.00% | – |
| Q3 2017 | $219,000 | -30.5% | 686,324 | +0.2% | 0.00% | – |
| Q2 2017 | $315,000 | -66.0% | 685,127 | -11.2% | 0.00% | – |
| Q1 2017 | $926,000 | +18420.0% | 771,287 | +132880.5% | 0.00% | – |
| Q1 2015 | $5,000 | -16.7% | 580 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | 0.0% | 580 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | -40.0% | 580 | 0.0% | 0.00% | – |
| Q2 2014 | $10,000 | 0.0% | 580 | 0.0% | 0.00% | – |
| Q1 2014 | $10,000 | -9.1% | 580 | 0.0% | 0.00% | – |
| Q4 2013 | $11,000 | -15.4% | 580 | +16.9% | 0.00% | – |
| Q3 2013 | $13,000 | +44.4% | 496 | 0.0% | 0.00% | – |
| Q2 2013 | $9,000 | – | 496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |